Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Allay Therapeutics has raised $57.5M in total funding. The most recent round was Series D. The last funding was announced in June 2025.
Allay Therapeutics's investors include New Enterprise Associates, Temasek Holdings, Arboretum Ventures, Brandon Capital, Lightstone Ventures.
Allay Therapeutics is headquartered in San Jose, United States.
Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation.
Allay Therapeutics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allay Therapeutics — Funding & Investors." VCBacked, June 5, 2025, https://www.vcbacked.co/company/allay-therapeutics. Accessed July 19, 2026.
VCBacked. (2025). Allay Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/allay-therapeutics
{{cite web |title=Allay Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allay-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated